Spruce Biosciences, Inc. (SPRB)
60.78
-2.52
(-3.98%)
USD |
NASDAQ |
Aug 28, 16:00
60.60
-0.18
(-0.30%)
After-Hours: 20:00
Spruce Biosciences 1 Year Total Returns (Daily) : 710.4% for Aug. 28, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 28, 2026 | 710.4% |
| August 27, 2026 | 746.3% |
| August 26, 2026 | 708.9% |
| August 25, 2026 | 697.5% |
| August 24, 2026 | 615.2% |
| August 21, 2026 | 506.8% |
| August 20, 2026 | 521.1% |
| August 19, 2026 | 494.1% |
| August 18, 2026 | 490.4% |
| August 17, 2026 | 487.3% |
| August 14, 2026 | 501.6% |
| August 13, 2026 | 435.1% |
| August 12, 2026 | 423.0% |
| August 11, 2026 | 407.2% |
| August 10, 2026 | 362.7% |
| August 07, 2026 | 311.5% |
| August 06, 2026 | 358.5% |
| August 05, 2026 | 360.3% |
| August 04, 2026 | 414.0% |
| August 03, 2026 | 427.7% |
| July 31, 2026 | 419.1% |
| July 30, 2026 | 430.5% |
| July 29, 2026 | 365.4% |
| July 28, 2026 | 413.6% |
| July 27, 2026 | 376.8% |
| Date | Value |
|---|---|
| July 24, 2026 | 370.8% |
| July 23, 2026 | 385.7% |
| July 22, 2026 | 395.5% |
| July 21, 2026 | 423.8% |
| July 20, 2026 | 439.4% |
| July 17, 2026 | 511.1% |
| July 16, 2026 | 486.6% |
| July 15, 2026 | 527.2% |
| July 14, 2026 | 499.5% |
| July 13, 2026 | 621.9% |
| July 10, 2026 | 809.5% |
| July 09, 2026 | 848.9% |
| July 08, 2026 | 848.5% |
| July 07, 2026 | 867.0% |
| July 06, 2026 | 854.9% |
| July 02, 2026 | 860.4% |
| July 01, 2026 | 885.3% |
| June 30, 2026 | 893.1% |
| June 29, 2026 | 934.8% |
| June 26, 2026 | 949.7% |
| June 25, 2026 | 905.1% |
| June 24, 2026 | 886.6% |
| June 23, 2026 | 893.1% |
| June 22, 2026 | 941.9% |
| June 18, 2026 | 871.6% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Biogen, Inc. | 64.72% |
| PTC Therapeutics, Inc. | 40.77% |
| ACADIA Pharmaceuticals, Inc. | 10.98% |
| Alnylam Pharmaceuticals, Inc. | -47.58% |
| Anika Therapeutics, Inc. | 128.6% |